Does Medicaid cover Foundayo (orforglipron) in 2026?
Medicaid is restrictive on weight-loss GLP-1s for the weight-loss indication, and reliably covers GLP-1s prescribed for type 2 diabetes. Foundayo (orforglipron) is not on their preferred formulary as of May 2026. Below is what to expect, what to ask, and your backup plan if denied. 10 of 50 state Medicaid programs (Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin) cover a weight-loss GLP-1 for adults, checking each state's own documents between September 20, 2026 and October 19, 2026, and the trend is negative: 7 programs ended coverage in 2026 (California, New Hampshire, Pennsylvania, and South Carolina (January 1), Utah (June 30), Massachusetts (July 3), and Rhode Island (October 1)). Check your state's Preferred Drug List (PDL).
What you'll actually pay for Foundayo (orforglipron) on Medicaid
| Path | Monthly cost |
|---|---|
| Medicaid insurance + savings card | N/A |
| Medicaid insurance, no savings card | $25–$100 |
| LillyDirect self-pay (no insurance) | $149 |
| Cash retail (full WAC) | $1,099 |
Medicaid prior authorization requirements
Based on Medicaid (varies by state)'s public formulary documents and PBM coverage policies for Foundayo (orforglipron) (and similar weight-loss GLP-1s) as of May 2026:
- Coverage and rules are set state-by-state
- Most state Medicaid programs cover GLP-1s for type 2 diabetes only
Coverage policies change frequently. Confirm against your specific plan's Summary of Benefits or by calling the member services number on your insurance card.
If Medicaid denies your Foundayo (orforglipron) prior auth
Three real options, in rough order of effort vs cost:
- Appeal the denial. Most denials are overturnable with the right documentation (BMI, comorbidity diagnosis, prior weight-loss attempts). Step-by-step appeal playbook.
- Switch to LillyDirect self-pay at $149/month. No insurance involved; you pay the manufacturer directly. Visit LillyDirect.
Foundayo (orforglipron) coverage on other major insurers
Other GLP-1s on Medicaid
Frequently asked questions
How do I know if my specific Medicaid plan covers Foundayo (orforglipron)?
Coverage varies dramatically by employer plan within the same carrier. Call the member-services number on your Medicaid insurance card and ask: "Is Foundayo (orforglipron) covered on my formulary, what tier, and does it require prior authorization?" Get the answer in writing or via the member portal. Your plan's Summary of Benefits and Coverage (SBC) document also lists the formulary tier.
Can I use the Foundayo (orforglipron) savings card with Medicaid?
No. Medicaid members are excluded from manufacturer savings cards by the federal anti-kickback statute, regardless of plan. Manufacturer direct self-pay programs (LillyDirect, NovoCare) remain open to government-insurance members because they are cash pricing, not copay assistance.
What if Medicaid requires step therapy before approving Foundayo (orforglipron)?
Step therapy means trying (and failing) an older or cheaper drug first. Common step drugs for GLP-1s are phentermine, topiramate, or older Saxenda. If your prescriber documents medical reasons you cannot tolerate the step drug (or have a contraindication), they can request a step-therapy exception. This is a separate request from the prior auth and often succeeds when properly documented. Full appeal playbook here.
Is it worth paying out of pocket through LillyDirect instead of fighting Medicaid?
LillyDirect self-pay is $149/month. If Medicaid's expected out-of-pocket cost (after PA approval and savings card) is at or below this number, insurance is the better deal. If your plan denies coverage entirely or requires step therapy you cannot complete, LillyDirect may be the faster path. The math gets clearer once you have either an approval or denial in hand.
Related guides
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.